These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 29587761)

  • 21. Molecular breath analysis supports altered amino acid metabolism in idiopathic pulmonary fibrosis.
    Gaugg MT; Engler A; Bregy L; Nussbaumer-Ochsner Y; Eiffert L; Bruderer T; Zenobi R; Sinues P; Kohler M
    Respirology; 2019 May; 24(5):437-444. PubMed ID: 30681243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mitigation of Oxidative Stress in Idiopathic Pulmonary Fibrosis Through Exosome-Mediated Therapies.
    Wang Z; Zhang Y; Li X
    Int J Nanomedicine; 2024; 19():6161-6176. PubMed ID: 38911503
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oxidant/Antioxidant Disequilibrium in Idiopathic Pulmonary Fibrosis Pathogenesis.
    Cameli P; Carleo A; Bergantini L; Landi C; Prasse A; Bargagli E
    Inflammation; 2020 Feb; 43(1):1-7. PubMed ID: 31297749
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Curcumin induced oxidative stress attenuation by N-acetylcysteine co-treatment: a fibroblast and epithelial cell in-vitro study in idiopathic pulmonary fibrosis.
    Rodriguez LR; Bui SN; Beuschel RT; Ellis E; Liberti EM; Chhina MK; Cannon B; Lemma M; Nathan SD; Grant GM
    Mol Med; 2019 Jun; 25(1):27. PubMed ID: 31195971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proteomic analysis of bronchoalveolar lavage fluid samples obtained from West Highland White Terriers with idiopathic pulmonary fibrosis, dogs with chronic bronchitis, and healthy dogs.
    Lilja-Maula LI; Palviainen MJ; Heikkilä HP; Raekallio MR; Rajamäki MM
    Am J Vet Res; 2013 Jan; 74(1):148-54. PubMed ID: 23270360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potential biomarkers for diagnosis and disease evaluation of idiopathic pulmonary fibrosis.
    Wang Q; Xie Z; Wan N; Yang L; Jin Z; Jin F; Huang Z; Chen M; Wang H; Feng J
    Chin Med J (Engl); 2023 Jun; 136(11):1278-1290. PubMed ID: 37130223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic significance of surfactant protein A, surfactant protein D, Clara cell protein 16, S100 protein, trefoil factor 3, and prostatic secretory protein 94 in idiopathic pulmonary fibrosis, sarcoidosis, and chronic pulmonary obstructive disease.
    Doubková M; Karpíšek M; Mazoch J; Skřičková J; Doubek M
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Oct; 33(3):224-234. PubMed ID: 27758987
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The Role of Bronchoalveolar Lavage in the Diagnosis of Idiopathic Pulmonary Fibrosis: An Investigation of the Relevance of the Protein Content].
    Schildge J; Frank J; Klar B
    Pneumologie; 2016 Jul; 70(7):435-41. PubMed ID: 27218212
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Significance of molecular biomarkers in idiopathic pulmonary fibrosis: A mini review.
    Chiba H; Otsuka M; Takahashi H
    Respir Investig; 2018 Sep; 56(5):384-391. PubMed ID: 30030108
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ROCK activation in lung of idiopathic pulmonary fibrosis with oxidative stress.
    Shimizu Y; Dobashi K; Sano T; Yamada M
    Int J Immunopathol Pharmacol; 2014; 27(1):37-44. PubMed ID: 24674677
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the lung microbiome as a therapeutic target in the management of idiopathic pulmonary fibrosis: role of antioxidant/antibiotic combination therapy.
    Varone F; Gibiino G; Gasbarrini A; Richeldi L
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6379-6386. PubMed ID: 31364146
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of antioxidants in the treatment of gastroesophageal reflux disease-associated idiopathic pulmonary fibrosis.
    Nelkine L; Vrolijk MF; Drent M; Bast A
    Curr Opin Pulm Med; 2020 Jul; 26(4):363-371. PubMed ID: 32452901
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum and BALF YKL-40 levels are predictors of survival in idiopathic pulmonary fibrosis.
    Korthagen NM; van Moorsel CH; Barlo NP; Ruven HJ; Kruit A; Heron M; van den Bosch JM; Grutters JC
    Respir Med; 2011 Jan; 105(1):106-13. PubMed ID: 20888745
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oxidative stress and antioxidants in the pathogenesis of pulmonary fibrosis: a potential role for Nrf2.
    Walters DM; Cho HY; Kleeberger SR
    Antioxid Redox Signal; 2008 Feb; 10(2):321-32. PubMed ID: 17999635
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Docosatetraenoyl LPA is elevated in exhaled breath condensate in idiopathic pulmonary fibrosis.
    Montesi SB; Mathai SK; Brenner LN; Gorshkova IA; Berdyshev EV; Tager AM; Shea BS
    BMC Pulm Med; 2014 Jan; 14():5. PubMed ID: 24468008
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sphingosine-1-phosphate is increased in patients with idiopathic pulmonary fibrosis and mediates epithelial to mesenchymal transition.
    Milara J; Navarro R; Juan G; Peiró T; Serrano A; Ramón M; Morcillo E; Cortijo J
    Thorax; 2012 Feb; 67(2):147-56. PubMed ID: 22106015
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Idiopathic pulmonary fibrosis (IPF) signaling pathways and protective roles of melatonin.
    Hosseinzadeh A; Javad-Moosavi SA; Reiter RJ; Hemati K; Ghaznavi H; Mehrzadi S
    Life Sci; 2018 May; 201():17-29. PubMed ID: 29567077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emerging therapeutic interventions for idiopathic pulmonary fibrosis.
    Chakraborty S; Chopra P; Ambi SV; Dastidar SG; Ray A
    Expert Opin Investig Drugs; 2014 Jul; 23(7):893-910. PubMed ID: 24766571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Personalized medicine in idiopathic pulmonary fibrosis: facts and promises.
    Spagnolo P; Tzouvelekis A; Maher TM
    Curr Opin Pulm Med; 2015 Sep; 21(5):470-8. PubMed ID: 26132817
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Do all patients with idiopathic pulmonary fibrosis warrant a trial of therapeutic intervention? A pro-con perspective.
    Moodley Y; Corte T; Richeldi L; King TE
    Respirology; 2015 Apr; 20(3):389-94. PubMed ID: 25727967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.